Global Allergy Summit 2027

Abstract Submission Guidelines & Scientific Awards

10–12 September 2027 | Taj Taal Kutir, Kolkata • Scientific presentations on 11–12 September 2027

Submission Deadline
30 April 2027
11:59 PM Indian Standard Time (IST)
Summit Dates
10–12 September 2027
Taj Taal Kutir, Kolkata
Scientific Presentations
11–12 September 2027
Oral & Poster Presentations

1. Presentation Formats

The Summit invites original research for oral or poster presentation. Presentation formats include:

Oral Presentation

Selected high-ranking abstracts will be presented orally, followed by discussion with the judges.

Poster Presentation

Presenters must attend their assigned poster session to present their work and respond to questions. The presentation format will be determined by the Scientific Committee.

Note: The presentation format will be determined by the Scientific Committee.

2. Submission Deadline & Registration

  • Submission deadline: 30 April 2027 at 11:59 PM Indian Standard Time (IST).
  • Abstracts must be submitted in English through the official abstract submission portal. Submissions by email or other channels will not be accepted.
  • Abstract submission may precede conference registration. Presenting authors of accepted abstracts must complete conference registration by the deadline stated in the acceptance communication to confirm their presentation.

3. Eligibility & Submission Requirements

  • Abstracts must report original scientific work with results available at submission. Narrative reviews, systematic reviews, meta-analyses, study protocols and abstracts without results are not eligible under this original-research submission track. Original case reports or series with systematic data collection and analysis may be submitted.
  • Work published as a full paper before submission is not eligible. Prior presentation at another meeting or publication as a conference abstract does not automatically exclude a submission, but must be disclosed in the portal. Duplicate submissions of the same work to this Summit are not permitted.
  • There is no limit on the number of abstracts submitted. Each presenting author may present a maximum of three accepted abstracts onsite, across oral and poster formats combined.
  • The presenting author must be listed among the authors, have made a substantive contribution to the work, and be able to explain the methods and findings. All co-authors must approve the abstract, author order and submission.
  • Authors are responsible for the accuracy, originality and integrity of their submission. Patient-identifying information must not appear in the abstract or presentation.

4. Abstract Format & Structure

Word Limit: Max 300 Words

The abstract body must not exceed 300 words. This limit includes the section headings and text under Background, Methods, Results and Conclusion. The title, author details, affiliations and separate ethics, funding and conflict-of-interest declarations are excluded.

Use the following structured headings:
Background
State the clinical or scientific context and the study objective.
Methods
Describe the study design, setting, participants, procedures and analysis, as applicable.
Results
Present the principal findings with relevant numerical data and statistical measures where appropriate. Statements such as “results will be presented” are not acceptable.
Conclusion
Provide a clear conclusion supported by the results, without overstating the findings.
  • Enter the title, author names, institutional affiliations and presenting author’s contact details in the designated portal fields. Define abbreviations at first use and avoid unnecessary abbreviations. Do not include references, tables or figures in the abstract body.
  • To support blinded review, do not include author names, affiliations, acknowledgements or other identifying details in the abstract body. Institutional ethics committee names and approval identifiers should be entered in the separate ethics field.

5. Ethics & Declarations

Ethics Committee Approval

Ethics Committee approval must have been obtained where required. State the approval status and reference number, where available, in the designated field. Where approval is exempt or not applicable, provide a brief explanation. Informed consent or an approved waiver must be in place where applicable.

Funding & Conflicts of Interest

Declare funding sources and relevant conflicts of interest, including a statement where there are none.

Prior Disclosures

Disclose prior presentation or conference-abstract publication in the designated field.

6. Abstract Categories

Select the category that best reflects the principal focus of the work. The Scientific Committee may reassign the category where appropriate.

A
Respiratory Allergy

Allergic rhinitis, rhinosinusitis, ocular allergy, asthma and related disorders.

B
Food, Drug and Insect Allergy

Food, Drug and Insect Allergy.

C
Sleep Medicine

Sleep Medicine.

D
Skin and Systemic Allergic Disorders

Anaphylaxis, urticaria, angioedema, dermatitis and related conditions.

E
Other Related Topics

Allergen immunotherapy, allergy diagnostics, clinical immunology, epidemiology, education and other relevant research.

The Scientific Committee may reassign the category where appropriate.

7. Scientific Awards and Age Eligibility

The following awards are open to presenting authors of abstracts selected for oral presentation:

Aged 40 Years or Younger

Allergy NextGenStar Award

Presenting authors aged 40 years or younger.

Aged 41 Years or Older

Allergy Excellence Award

Presenting authors aged 41 years or older.

Award Guidelines & Eligibility Criteria

  • Age Eligibility Cutoff: Age eligibility will be determined by age in completed years as on 11 September 2027, uniformly for all presenters, irrespective of their presentation date. Proof of date of birth may be requested to verify eligibility.
  • Submission Indication: Authors wishing to be considered for an award must indicate this at submission and select the appropriate category. Award eligibility will be verified separately from blinded scientific review. Thesis-based and other original research are encouraged.
  • Judging Criteria & In-Person Delivery: Awards will recognise originality, methodological rigour, relevance, clarity of presentation, responses to judges’ questions and the presenting author’s contribution to the research. Award consideration requires the eligible presenting author to deliver the oral presentation in person.
  • Conferral & Discretion: One or more awards may be conferred in each category, based on scientific merit and at the discretion of the Scientific and Awards Committee. Eligibility does not guarantee oral selection or an award. The Committee may withhold an award if the required scientific standard is not met.

8. Review & Notification

  • Abstracts will undergo blinded scientific review based on originality, study design and methodology, quality of results, relevance and potential contribution to research or clinical practice. Reviewers and judges must disclose relevant conflicts of interest and recuse themselves where appropriate.
  • The Scientific Committee’s decisions on acceptance, category assignment and allocation to oral or poster presentation are final. The award judges’ decisions are final.
  • Acceptance decisions, presentation schedules, registration requirements and detailed oral or poster instructions will be communicated to the presenting author through the contact details supplied at submission. Authors should ensure that these details are accurate and regularly monitored.
  • The Scientific Committee may reject or withdraw an abstract for plagiarism, duplicate submission, material inaccuracies, ethical concerns or failure to comply with these guidelines.

9. Changes & Withdrawals

  • Requests to withdraw an abstract or change the presenting author must be submitted promptly through the official conference contact channel and require Scientific Committee approval. A change of presenter will require reassessment of award eligibility. Substantive changes to accepted abstracts require Committee approval.
  • Presenting authors must attend their allocated session. Failure to register by the communicated deadline or to present may result in removal from the scientific programme and loss of award consideration.
Important: Authors must ensure that all contact and submission details are verified and regularly monitored to prevent loss of presentation slot or award consideration.

Ready to Submit?

Abstracts must be submitted in English through the official abstract submission portal before 30 April 2027 at 11:59 PM IST. Please carefully review all guidelines and structured formats before submitting.

Submit Abstract Online
Need Assistance?

Conference Secretariat
Email: Info@globalallergysummit2027.com  |  Phone: +91 85952 51325